USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Attractiveness and Hurdles for Stakeholders in the Next 5 Years
16-Jun-2015
North America
Market Research
9AB9-00-22-00-00
LS00071-NA-MR_16912
The growing population base, driven by increased life expectancy and domestic investment, is expected to continuously accelerate GDP in Malaysia. Significant growth of healthcare expenditure is expected in the country to facilitate the improvement of medical access and provide companies with revenue-earning opportunities from 2015. Positive macroeconomic and healthcare market trends are expected to fast-track the pharmaceutical market in Malaysia. The study explores the broad competitive landscape, demand dynamics, and regulatory environment that investors must consider while entering this pharmaceutical market.
Key Findings
Key Questions this Study will Answer
Overview of the Malaysian Healthcare Market
Overview of the Malaysian Healthcare Market (continued)
Overview of the Malaysian Healthcare Market (continued)
Overview of the Malaysian Healthcare Market (continued)
Overview of the Malaysian Healthcare Market (continued)
Overview of the Malaysian Healthcare Market (continued)
Overview of the Malaysian Healthcare Market (continued)
Overview of Malaysian Public and Private Healthcare Systems
Overview of Malaysian Public and Private Healthcare Systems (continued)
Algorithm of Malaysian Healthcare Systems
Algorithm of Private Healthcare Systems
Future Roadblocks
Distribution of Household Income Up to 2012
Key Driver in the Malaysian Hospital Market—Growing Admission of Elderly Population
Key Driver in the Malaysian Private Hospital Segment—Medical Tourism
Key Drivers in the Malaysian Hospital Market—Chronic and Lifestyle Diseases
Overview of the Malaysian Pharmaceutical Market
Revenue Forecast for the Malaysian Pharmaceutical Market
Pharmaceutical Market Components by Percentage
Malaysian Pharmaceutical Market—Segmentation
Malaysian Pharmaceutical Market—Segmentation (continued)
Halal Medicine Market in Malaysia
Malaysian Regulatory Landscape
Key Driver in the Malaysian Pharmaceutical Market—NKEA
Impact of GST on Malaysian Pharmaceutical Market
Drivers
Restraints
Home-grown Participants in the Malaysian Pharmaceutical Market
CCM Pharmaceuticals Sdn Bhd
Kotra Pharma (M) Sdn Bhd
Pharmaniaga Berhad
YSP Industries (M) Sdn Bhd
Hovid Berhad
MNC Participants in the Malaysian Pharmaceutical Market
Pfizer Malaysia
Merck Sharp & Dohme (MSD)
Eli Lilly
GlaxoSmithKline (GSK)
Johnson & Johnson Sdn Bhd
PESTLE Analysis
Porter Five Forces Analysis for the Malaysian Pharmaceutical Market
The Future of the Malaysian Pharmaceutical Market—Key Focus Areas
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Lightbox Content | World Cancer Day 2019|Get 15% discount for all Healthcare studies |https://store.frost.com/contacts/?utm_source=PD&utm_medium=lightbox&utm_campaign=HEALTHCARE_CANCER2019 |
| Author | Rageshwary Ramupillai |
| WIP Number | 9AB9-00-22-00-00 |
| Is Prebook | No |
Analysis of the Pharmaceutical Market in Malaysia
$1,500.00
Special Price $1,125.00 save 25 %